Pharmaceutical CEO Refuses To Testify To Congress, Smirks at Panel

News
SHRKELI_1454628127464.jpeg

Pharmaceutical CEO Martin Shkreli refused to testify before Congress Thursday.

The House Oversight and Government Reform Committee called for the hearing after Shkreli raised the price of Daraprim more than 5,000%, to $750.  Daraprim is used to treat toxoplasmosis.  It can also prevent malaria and other kinds of infections.

“I call this money ‘blood money'” said Rep. Elijah Cummings (D-MD) during the hearing.  He lashed out at Shkreli for the price hike.

Shkreli’s attorney tried speaking on his client’s behalf, but was told to sit back down.  Cummings then urged Shkreli to lower the drug’s price.  But, Shkreli laughed at him.

Shkreli took to social media after the hearing to call Congress, “imbeciles.”

Copyright 2019 Nexstar Broadcasting, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Made in the Stateline

More Made in the Stateline

Education Matters

More Education Matters

Behind the Badge

More Behind the Badge

Stateline Strong

More Stateline Strong